Citations

PASSARIELLO, M. et al. Comparative Analysis of a Human Neutralizing mAb Specific for SARS-CoV-2 Spike-RBD with Cilgavimab and Tixagevimab for the Efficacy on the Omicron Variant in Neutralizing and Detection Assays. International Journal of Molecular Sciences, [s. l.], v. 24, n. 12, p. 10053, 2023. DOI 10.3390/ijms241210053. Disponível em: https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=owf&AN=164649114&authtype=uid&user=rmabrowserextension&password=Br0wserExtension789! Acesso em: 29 set. 2023.

Passariello M, Esposito S, Manna L, et al. Comparative Analysis of a Human Neutralizing mAb Specific for SARS-CoV-2 Spike-RBD with Cilgavimab and Tixagevimab for the Efficacy on the Omicron Variant in Neutralizing and Detection Assays. International Journal of Molecular Sciences. 2023;24(12):10053. doi:10.3390/ijms241210053

Passariello, M., Esposito, S., Manna, L., Rapuano Lembo, R., Zollo, I., Sasso, E., Amato, F., & De Lorenzo, C. (2023). Comparative Analysis of a Human Neutralizing mAb Specific for SARS-CoV-2 Spike-RBD with Cilgavimab and Tixagevimab for the Efficacy on the Omicron Variant in Neutralizing and Detection Assays. International Journal of Molecular Sciences, 24(12), 10053. https://doi.org/10.3390/ijms241210053

Passariello, Margherita, Speranza Esposito, Lorenzo Manna, Rosa Rapuano Lembo, Immacolata Zollo, Emanuele Sasso, Felice Amato, and Claudia De Lorenzo. 2023. “Comparative Analysis of a Human Neutralizing MAb Specific for SARS-CoV-2 Spike-RBD with Cilgavimab and Tixagevimab for the Efficacy on the Omicron Variant in Neutralizing and Detection Assays.” International Journal of Molecular Sciences 24 (12): 10053. doi:10.3390/ijms241210053.

Passariello, M. et al. (2023) ‘Comparative Analysis of a Human Neutralizing mAb Specific for SARS-CoV-2 Spike-RBD with Cilgavimab and Tixagevimab for the Efficacy on the Omicron Variant in Neutralizing and Detection Assays’, International Journal of Molecular Sciences, 24(12), p. 10053. doi:10.3390/ijms241210053.

Passariello, M, Esposito, S, Manna, L, Rapuano Lembo, R, Zollo, I, Sasso, E, Amato, F & De Lorenzo, C 2023, ‘Comparative Analysis of a Human Neutralizing mAb Specific for SARS-CoV-2 Spike-RBD with Cilgavimab and Tixagevimab for the Efficacy on the Omicron Variant in Neutralizing and Detection Assays’, International Journal of Molecular Sciences, vol. 24, no. 12, p. 10053, viewed 29 September 2023, .

Passariello, Margherita, et al. “Comparative Analysis of a Human Neutralizing MAb Specific for SARS-CoV-2 Spike-RBD with Cilgavimab and Tixagevimab for the Efficacy on the Omicron Variant in Neutralizing and Detection Assays.” International Journal of Molecular Sciences, vol. 24, no. 12, June 2023, p. 10053. EBSCOhost, https://doi.org/10.3390/ijms241210053.

Passariello, Margherita, Speranza Esposito, Lorenzo Manna, Rosa Rapuano Lembo, Immacolata Zollo, Emanuele Sasso, Felice Amato, and Claudia De Lorenzo. “Comparative Analysis of a Human Neutralizing MAb Specific for SARS-CoV-2 Spike-RBD with Cilgavimab and Tixagevimab for the Efficacy on the Omicron Variant in Neutralizing and Detection Assays.” International Journal of Molecular Sciences 24, no. 12 (June 15, 2023): 10053. doi:10.3390/ijms241210053.

Passariello M, Esposito S, Manna L, Rapuano Lembo R, Zollo I, Sasso E, et al. Comparative Analysis of a Human Neutralizing mAb Specific for SARS-CoV-2 Spike-RBD with Cilgavimab and Tixagevimab for the Efficacy on the Omicron Variant in Neutralizing and Detection Assays. International Journal of Molecular Sciences [Internet]. 2023 Jun 15 [cited 2023 Sep 29];24(12):10053. Available from: https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=owf&AN=164649114&authtype=uid&user=rmabrowserextension&password=Br0wserExtension789!